In an open-label, multicentre prospective cohort study, Viz HCM (Viz.ai)—an AI-ECG software alerting of suspected HCM—was implemented at five healthcare systems between January and December 2023 to identify patients >18 years of age without prior HCM diagnosis.
Viz HCM